Luxembourg vs New Zealand: Share of the population living with HIV receiving antiretroviral therapy
Luxembourg
83.8%
in 2024
New Zealand
84.2%
in 2024
Luxembourg rank
43rd
New Zealand rank
41st
Share of the population living with HIV receiving antiretroviral therapy over time
- Luxembourg
- New Zealand
How they compare
New Zealand currently reports 84.2% against 83.8% in Luxembourg, a difference of 0.4%.
The two have swapped places 12 times across 35 shared years of data; in 1990 it was New Zealand ahead.
Luxembourg ranks 43rd and New Zealand ranks 41st of 149 countries.
Across the 4 decades both report, Luxembourg averaged higher in 2 and New Zealand in 2.
Head to head by decade
| Decade | Luxembourg | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 14.0% | 13.4% | 0.6% | Luxembourg |
| 2000s | 44.5% | 43.2% | 1.3% | Luxembourg |
| 2010s | 63.8% | 64.2% | 0.4% | New Zealand |
| 2020s | 79.0% | 79.2% | 0.1% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv receiving antiretroviral therapy, Luxembourg or New Zealand?
- New Zealand, at 84.2% against 83.8% in Luxembourg as of 2024.
- What is the difference in share of the population living with hiv receiving antiretroviral therapy between Luxembourg and New Zealand?
- 0.4%, with New Zealand ahead.
- How many years of comparable data are there for Luxembourg and New Zealand?
- 35 years are reported by both, from 1990 to 2024.
- How do Luxembourg and New Zealand rank globally for share of the population living with hiv receiving antiretroviral therapy?
- Luxembourg ranks 43rd and New Zealand ranks 41st of 149 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.